• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

William (Bill) Barry, PhD


  • Liu JF, Kindelberger D, Doyle C, Lowe A, Barry WT, Matulonis UA.Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.Gynecol Oncol. 2013 Aug 13.
  • Zhou YH, Barry WT, Wright FA.Empirical pathway analysis, without permutation.Biostatistics. 2013 Jul;14(3):573-85.
  • Mandelblatt JS, Faul LA, Luta G, Makgoeng SB, Isaacs C, Taylor K, Sheppard VB, Tallarico M, Barry WT, Cohen HJ.Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901.J Clin Oncol. 2012 Jul 20;30(21):2609-14.
  • Ibarra-Drendall C, Troch MM, Barry WT, Broadwater G, Petricoin EF, Wulfkuhle J, Liotta LA, Lem S, Baker JC, Ford AC, Wilke LG, Zalles C, Kuderer NM, Hoffman AW, Shivraj M, Mehta P, Williams J, Tolbert N, Lee LW, Pilie PG, Yu D, Seewaldt VL.Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways.Breast Cancer Res Treat. 2012 Apr;132(2):487-98.
  • Owzar K, Barry WT, Jung SH.Statistical considerations for analysis of microarray experiments.Clin Transl Sci. 2011 Dec;4(6):466-77. Review.
  • Gatti DM, Barry WT, Nobel AB, Rusyn I, Wright FA.Heading down the wrong pathway: on the influence of correlation within gene sets.BMC Genomics. 2010;11:574.
  • Geradts J, Bean SM, Bentley RC, Barry WT.The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic features.Cancer Invest. 2010 Nov;28(9):969-77.
  • Barry WT, Kernagis DN, Dressman HK, Griffis RJ, Hunter JD, Olson JA, Marks JR, Ginsburg GS, Marcom PK, Nevins JR, Geradts J, Datto MB.Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome.J Clin Oncol. 2010 May 1;28(13):2198-206.